Indications
Ucedane is indicated in treatment of: hyperammonaemia due to N-acetylglutamate synthase primary deficiency; Hyperammonaemia due to isovaleric acidaemia; Hyperammonaemia due to methymalonic acidaemia; Hyperammonaemia due to propionic acidaemia.
Composition
- Active substance
- carglumic acid
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ucedane
- Active substance
- carglumic acid
- ATC code
- A16AA05
- Therapeutic area
- Hyperammonemia, Amino Acid Metabolism, Inborn Errors
- Marketing authorisation holder
- Eurocept International BV